{"name":"Nalbuphine","slug":"nalbuphine","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Nalbufina","Nalbuphinum","Intapan","N-Cyclobutylmethyl-4,5α-epoxy-3,6α,14-morphinantriol","17-(Cyclobutylmethyl)-4,5α-epoxymorphinan-3,6α,14-triol","Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, (5α,6α)-","243-901-6","17-cyclobutylmethyl-4,5α-epoxymorphinan-3,6α,14-triol","Nalbuphine (1.0mg/ml in Acetonitrile)","Intapan (TN)"],"brands":[],"scraped":true,"has_structure":true,"cid":5311304,"classes":[{"name":"opioid","href":"/class/opioid"}],"families":[{"name":"2-benzylpiperidine","href":"/substituted/2-benzylpiperidine"}],"physical":[{"label":"Molecular mass","value":"357.40 g/mol","copyable":false},{"label":"Melting point","value":"230 °C as HCl salt","copyable":false},{"label":"Solubility","value":"35.5 mg/mL at 25 °C as HCl salt","copyable":false},{"label":"Predicted LogP","value":"0.2","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>21</sub>H<sub>27</sub>NO<sub>4</sub>","copyable":true},{"label":"IUPAC name","value":"(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","copyable":true},{"label":"SMILES","value":"C1CC(C1)CN2CC[C@]34[C@@H]5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O","copyable":true},{"label":"InChI","value":"InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1","copyable":true},{"label":"InChIKey","value":"NETZHAKZCGBWSS-CEDHKZHLSA-N","copyable":true},{"label":"CAS number","value":"20594-83-6","copyable":true},{"label":"UNII","value":"L2T84IQI2K","copyable":true},{"label":"PubChem CID","value":"5311304","copyable":true}],"pharmacokinetics":[{"label":"Onset","value":"• Oral: &lt;1 hour, • Rectal: &lt;30 minutes, • Intravenous injection: 2–3 minutes, • Intramuscular injection: &lt;15 minutes, • Subcutaneous injection: &lt;15 minutes","copyable":false},{"label":"Elimination half-life","value":"~5 hours (3–6 hours)","copyable":false},{"label":"Duration of action","value":"3–6 hours","copyable":false},{"label":"Metabolism","value":"Liver (glucuronidation)<a href=\"#cite_note-3\"><sup>[3]</sup></a>","copyable":false},{"label":"Excretion","value":"Urine, bile, feces; 93% within 6 hours<a href=\"#cite_note-4\"><sup>[4]</sup></a>","copyable":false},{"label":"Routes of administration","value":"Intravenous, intramuscular, subcutaneous","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Dog",[{"kind":"LD50","organism":"Dog","route":"Oral","dose":"1100 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Nalbuphine hydrochloride","name":"hydrochloride","slug":"nalbuphine_hydrochloride","drawn":true}],"esters":[],"chirality":"absolute","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N02","description":"Analgesics"},{"code":"N02A","description":"Opioids"},{"code":"N02AF","description":"Morphinan derivatives"},{"code":"N02AF02","description":"Nalbuphine"}],"mesh":[{"name":"Analgesics, Opioid","id":"M0001068"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"OPRM1","mechanisms":["shared target"],"partners":10,"contraindicated":1},{"target":"OPRK1","mechanisms":["shared target"],"partners":7,"contraindicated":1},{"target":"OPRD1","mechanisms":["shared target"],"partners":1,"contraindicated":1}],"mechanism":"The exact mechanism of action is unknown, but is believed to interact with an opiate receptor site in the CNS (probably in or associated with the limbic system). The opiate antagonistic effect may result from competitive inhibition at the opiate receptor, but may also be a result of other mechanisms. Nalbuphine is thought primarily to be a kappa agonist. It is also a partial mu antagonist analgesic, with some binding to the delta receptor and minimal agonist activity at the sigma receptor.","side_effects":{"drug_id":4419,"drug_name":"nalbuphine","url":"https://sideeffects.embl.de/drugs/4419/pt","atc_codes":["N02AF02"],"side_effects":[{"name":"Vomiting","cui":"C0042963"},{"name":"Vertigo","cui":"C0042571"},{"name":"Dry mouth","cui":"C0043352"},{"name":"Headache","cui":"C0018681"},{"name":"Abdominal pain","cui":"C0000737"},{"name":"Gastrointestinal pain","cui":"C0687713"},{"name":"Anxiety","cui":"C0003467"},{"name":"Asthenia","cui":"C0004093"},{"name":"Asthma","cui":"C0004096"},{"name":"Bronchospasm","cui":"C0006266"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Delusion","cui":"C0011253"},{"name":"Depersonalisation","cui":"C0011551"},{"name":"Depression","cui":"C0011570"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Dyspepsia","cui":"C0013395"},{"name":"Dyspnoea","cui":"C0013404"},{"name":"Oedema","cui":"C0013604"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Foetal death","cui":"C0015927"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Flushing","cui":"C0016382"},{"name":"Hallucination","cui":"C0018524"},{"name":"Cardiac arrest","cui":"C0018790"},{"name":"Hostility","cui":"C0020039"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypertension","cui":"C0020538"},{"name":"Hypotension","cui":"C0020649"},{"name":"Laryngeal oedema","cui":"C0023052"},{"name":"Muscle spasms","cui":"C0037763"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Hypoaesthesia","cui":"C0020580"},{"name":"Sensory loss","cui":"C0278134"},{"name":"Pruritus","cui":"C0033774"},{"name":"Pulmonary oedema","cui":"C0034063"},{"name":"Convulsion","cui":"C0036572"},{"name":"Shock","cui":"C0036974"},{"name":"Stridor","cui":"C0038450"},{"name":"Swelling","cui":"C0038999"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Tachycardia","cui":"C0039231"},{"name":"Tremor","cui":"C0040822"},{"name":"Shakiness","cui":"C0392703"},{"name":"Urticaria","cui":"C0042109"},{"name":"Wheezing","cui":"C0043144"},{"name":"Pollakiuria","cui":"C0042023"},{"name":"Micturition urgency","cui":"C0085606"},{"name":"Agitation","cui":"C0085631"},{"name":"Injection site reaction","cui":"C0151735"},{"name":"Respiratory arrest","cui":"C0162297"},{"name":"Dysphoria","cui":"C0233477"},{"name":"Speech disorder","cui":"C0037822"},{"name":"Euphoric mood","cui":"C0235146"},{"name":"Dysgeusia","cui":"C0013378"},{"name":"Erythema","cui":"C0041834"},{"name":"Vision blurred","cui":"C0344232"},{"name":"Feeling hot","cui":"C2939147"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Respiratory distress","cui":"C0476273"},{"name":"Hyperhidrosis","cui":"C0020458"},{"name":"Paraesthesia","cui":"C0030554"},{"name":"Somnolence","cui":"C2830004"}],"indications":[{"name":"Pain","cui":"C0030193"}]},"effects":{"groups":[["Physical Effects",["Constipation","Cough suppression","Difficulty urinating","Itchiness","Nausea","Pain relief","Pupil constriction","Respiratory depression","Sedation","Stomach cramp"]],["Cognitive Effects",["Anxiety suppression","Cognitive euphoria","Compulsive redosing","Increased music appreciation","Thought deceleration"]],["Visual Effects",["Double vision"]]]},"usernotes":[{"user":"nervewing","user_slug":"nervewing","external":false,"note":{"substance":"Nalbuphine","composite":false,"routes":[],"dosages":[],"classes":[],"forms":[],"sources":[],"indications":[],"effects":[],"conditional_effects":[],"after_effects":[],"tolerance":[],"odor":[],"notes":[]}}],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"A2","act":null,"refs":[5]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"United States","status":"Rx only (unscheduled) Schedule IV in some states","act":null,"refs":[6]},{"jurisdiction":"Australia","status":"Schedule 4","act":null,"refs":[]},{"jurisdiction":"Other","status":"Federally Uncontrolled (RX-only), except in KY, C-IV","act":null,"refs":[7]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Nalbuphine"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/5311304"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q277979"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB00844"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL895"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A7454"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=20594-83-6"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0014982"},{"source":"KEGG","url":"https://www.kegg.jp/entry/C07251"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID8023345"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Nalbuphine"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/L2T84IQI2K"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/4419/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 5311304, Nalbuphine. Accessed November 20, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/5311304>https://pubchem.ncbi.nlm.nih.gov/compound/5311304</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Nalbuphine. UNII: L2T84IQI2K. Global Substance Registration System. Accessed November 20, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/L2T84IQI2K>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/L2T84IQI2K</a>","Waldman SD. Pain Management E-Book. Elsevier Health Sciences. 9 June 2011. <a href='https://books.google.com/books?id=O6AojTbeXoEC&amp;pg=PA910'>https://books.google.com/books?id=O6AojTbeXoEC&amp;pg=PA910</a>","Yoo YC, Chung HS, Kim IS, Jin WT, Kim MK. Determination of nalbuphine in drug abusers&#39; urine. Journal of Analytical Toxicology. Mar–Apr 1995; 19(2):120–123. PMID 7769781. <a href='https://doi.org/10.1093/jat/19.2.120'>https://doi.org/10.1093/jat/19.2.120</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>","Nalbuphine Hydrochloride. DEA - Diversion Control Division. <a href='https://www.deadiversion.usdoj.gov/drug_chem_info/nalbuphine.pdf'>https://www.deadiversion.usdoj.gov/drug_chem_info/nalbuphine.pdf</a>","Kentucky Penal Code: Title 902 Chapter 55 Regulation 015 - Controlled Substances. Kentucky Law. <a href='https://apps.legislature.ky.gov/law/kar/titles/902/055/015/'>https://apps.legislature.ky.gov/law/kar/titles/902/055/015/</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 12:36:03","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 12:35:59","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 12:35:59","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 12:36:00","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 12:35:59","note":"hmdb.ca refused automated access to HMDB0014982"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 12:36:00","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 12:35:58","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 12:35:59","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 12:35:59","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 12:35:59","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 12:35:59","note":null}],"description":"Nalbuphine is a opioid substance."}